Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.
about
An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive ImmunityProtective ventilation of patients with acute respiratory distress syndromeBench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.Serum biomarkers in acute respiratory distress syndrome an ailing prognosticatorGenetic variant associations of human SP-A and SP-D with acute and chronic lung injuryVitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS)Cytochrome b5 and cytokeratin 17 are biomarkers in bronchoalveolar fluid signifying onset of acute lung injuryA phase II randomized placebo-controlled trial of omega-3 fatty acids for the treatment of acute lung injurySubphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.Prediction of non-recovery from ventilator-demanding acute respiratory failure, ARDS and death using lung damage biomarkers: data from a 1200-patient critical care randomized trial.Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot studySoluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injuryPrognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injuryPlasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients.Genetic polymorphisms associated with acute lung injury.Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndromeThe role of matrix metalloproteinase-9 in cigarette smoke-induced emphysema.Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome.Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury.Beyond mortality: future clinical research in acute lung injury.Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.Activation of the Wnt/β-catenin signaling pathway by mechanical ventilation is associated with ventilator-induced pulmonary fibrosis in healthy lungsBiomarkers of acute lung injury: worth their salt?The association between BMI and plasma cytokine levels in patients with acute lung injury.The Esophageal Pressure-Guided Ventilation 2 (EPVent2) trial protocol: a multicentre, randomised clinical trial of mechanical ventilation guided by transpulmonary pressure.Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors.Surfactant protein D in human lung diseases.Serum surfactant protein D (SP-D) is a prognostic marker of poor outcome in patients with A/H1N1 virus infection.Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells.Fetal and neonatal samples of a precursor surfactant protein B inversely related to gestational age.The acute respiratory distress syndrome: pathogenesis and treatmentAcute lung injury: epidemiology, pathogenesis, and treatment.Biomarkers in acute lung injury--marking forward progress.Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosisFactors influencing the measurement of plasma/serum surfactant protein D levels by ELISA.Acute respiratory distress syndrome: A clinical reviewBiological markers of lung injury before and after the institution of positive pressure ventilation in patients with acute lung injury
P2860
Q21131225-A030A455-2171-406A-BEEA-7968F42C6FF0Q24791200-536B29DB-507F-4D71-A12E-71A3A9DE1C27Q24800694-99A946D8-05AB-44C8-9C5B-C6DA7B3B693AQ24815239-A40958CC-EF07-4A04-A064-4B95CA903F58Q28256206-3F3304EE-81BA-4733-AA11-BCC7C0893314Q28647828-79755C64-8E85-4ACF-87A5-E19F89A1238CQ28727445-B5CBA040-1F4F-4FB4-B83F-1B507C140D49Q30501707-115D1C5C-63A5-4214-A06B-9B18B712730AQ30826105-54AC8841-9B51-4A89-A867-2BFDC3882548Q30951627-D3975EF4-E814-4883-9230-EDF3C51AD018Q31083146-34D06DEB-7877-40CD-84C3-BBA47677036BQ31143915-8818EB6E-7D8B-420F-B681-513F65B8CD30Q33301961-5868D3FF-57AA-44EB-A21F-CC6C71C33226Q33356631-E4494BA7-0109-443A-9617-C0AD385C8C36Q33512670-98E570E7-2213-4F82-B29F-EABE43E91719Q33531552-24AD3D68-3511-48ED-9B9C-FA283C97155FQ33569219-627287E5-6270-4FC5-9C2B-7DA138F355A6Q33682542-FD8EB115-6716-4B11-AB7D-BC5181CFDC58Q33740494-87DBBF29-34D9-4BDF-84BC-76C68FD90A85Q33750995-460E8DD4-AD9F-44DF-B308-2768AB825E10Q33808300-DD09CF0C-8037-4BE6-B480-4C13DA6E1AA6Q33868624-C43FB1EB-5CA8-45B5-ABEE-D2C9FE98E218Q33994636-CA81C8EA-2F40-4408-A31D-AE5A519155F4Q34004876-E096396A-87C1-4A73-A7B7-D585D8FA3204Q34025958-7D463B81-F597-47DF-84FC-F82CEC084BB0Q34094906-8B854AD6-1708-47F3-AC20-51BB16C6BB78Q34130717-920D065E-9389-4976-B5A1-6ED365E6699EQ34299206-1575A6D3-5BF6-4EC0-8947-576A0585AA6CQ34302302-DC083E81-5D21-466A-B407-38F0AA425D6CQ34567354-4ED5419A-3CFD-40C1-B394-26A3E6919E36Q34667220-891C9B06-D659-4052-8E83-540DB4A7DFDFQ34784921-FA7E1CA3-1584-4CD0-8088-35EED83FC07CQ35013598-7C932DFE-CDFE-49A4-8435-56D7F8530744Q35025114-BA11F3E4-A5F0-4C11-86F9-2B6CBCF54540Q35097126-E7DD6352-AE18-460E-81E7-89F45CC422D4Q35100674-8B792917-B972-4699-B0B0-8DA6CF2751B6Q35143037-8E3061E6-B811-44C9-8005-EEFB7ECE213AQ35387845-DCBD782D-9796-4C0B-B6E5-5586D12DDDA2Q35412409-B021CC1A-E799-45B3-AAEE-B39D52142A08Q35544777-EC8C7639-1A89-4B8E-B616-8A2C897E6E1A
P2860
Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Plasma surfactant protein leve ...... tients with acute lung injury.
@ast
Plasma surfactant protein leve ...... tients with acute lung injury.
@en
type
label
Plasma surfactant protein leve ...... tients with acute lung injury.
@ast
Plasma surfactant protein leve ...... tients with acute lung injury.
@en
prefLabel
Plasma surfactant protein leve ...... tients with acute lung injury.
@ast
Plasma surfactant protein leve ...... tients with acute lung injury.
@en
P2093
P2860
P356
P1433
P1476
Plasma surfactant protein leve ...... tients with acute lung injury.
@en
P2093
Acute Respiratory Distress Syndrome Network
M A Matthay
M D Eisner
P2860
P304
P356
10.1136/THORAX.58.11.983
P407
P577
2003-11-01T00:00:00Z